| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +857.0% |
| Cost of Revenue | $2.5M | +765.4% |
| Gross Profit | $1.6M | +1051.0% |
| R&D Expense | $3.1M | +310.5% |
| SG&A Expense | $521K | -96.6% |
| Operating Income | -$26.4M | -64.3% |
| Interest Expense | $18K | -84.9% |
| Pre-tax Income | -$32.3M | -98.2% |
| Income Tax | $111K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.9M | +682.7% |
| Inventory | $66K | — |
| Current Assets | $65.7M | +525.5% |
| Total Assets | $94.3M | +242.6% |
| Current Liabilities | $7.1M | +24.4% |
| Total Liabilities | $43.2M | +395.7% |
| Stockholders' Equity | $47.9M | +193.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.7M | -208.5% |
| Capital Expenditures | $9.7M | +315.0% |
| Investing Cash Flow | -$11.4M | -363.6% |
| Financing Cash Flow | $82.5M | +516.6% |
| Free Cash Flow | -$26.4M | -240.5% |
| +1917.2% |
| Net Income | -$32.4M | -99.0% |
| EPS (Basic) | -$0.63 | -28.6% |
| EPS (Diluted) | -$0.63 | -28.6% |